Ortho-Clinical and Quotient Strike $69M Deal for Blood Transfusion Test

Saturday, February 7, 2015

Source: Fierce Diagnostics

Ortho-Clinical Diagnostics has signed an exclusive deal worth up to $69 million with commercial-stage company Quotient to distribute and sell a blood transfusion diagnostics platform in development.

The Quotient platform, dubbed MosaiQ, aims to shorten the time it takes to get test results and to offer more comprehensive matching of donor and patient blood than currently available transfusion diagnostic instruments.

View All News »